STL Volume 17 Number 9

Update on drugs, approval dates, and comments. Delayed-release prednisone tablets (Rayos®), Imiquimod 3.75% cream (Zyclara®), Lidocaine topical 5% patch, Clobetasol propionate 0.05% shampoo are covered.

Device-based therapies are promising alternatives for the treatment of onychomycosis because they can mitigate some of the negative factors associated with treatment failure. This article reviews the case for laser and light based therapies, for the treatment of nail fungus.

Propionibacterium acnes (P. acnes) is an anaerobic bacteria implicated in the pathogenesis of acne. Current treatment guidelines offer strategies to limit the potential for resistance while achieving optimal outcome in the management of inflammatory and non-inflammatory acne.